XBiotech Inc. XBIT
Set alert
1.98 USD +0.06 +3.13%
As of Nov 3, 2:03 PM ET
1.90 Day range 2.00
1.80 52-week range 3.44
- YTD
- -17.15%
- 1 year
- -13.54%
- Open
- 1.90
- Prev close
- 1.92
- Mkt cap
- 60.37M
- Vol
- 40.74K
- Avg vol
- 56.45K
- EPS
- -1.48
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.90
- High
- 2.00
- Forward P/E
- 34.62
- Beta
- 0.00
- Short ratio
- 15.03
- Inst. own
- 16.19%
- Dividend
- 0.00
- Ex-div date
- Jul 14, 2021
- Earnings
- Nov 9, 2023
- 50-d avg
- 7.07
- 200-d avg
- 7.11
- 1y target
- 0.00
3M chart
Signals (20)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 21, 2026 | 1 week ago |
| RSI: Oversold | Oct 19, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 16, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 13, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 13, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 8, 2026 | 3 weeks ago |
| MACD: Buy Signal | Sep 22, 2026 | 1 month ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| SMA: Bullish | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| SMA: Bullish | Aug 24, 2026 | 2 months ago |
| SMA: Bearish | Aug 21, 2026 | 2 months ago |
| SMA: Bullish | Aug 19, 2026 | 2 months ago |
| SMA: Bearish | Aug 18, 2026 | 2 months ago |
| SMA: Bearish | Aug 14, 2026 | 2 months ago |
| RSI: Overbought | Aug 12, 2026 | 2 months ago |
| SMA: Bullish | Aug 11, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 5, 2026 | 3 months ago |
Financial health
Altman Z-Score
5.12 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 5
Valuation
P/E -1.6×
FY 2016 5y median -3.2× FY 2025
P/S 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.5×
FY 2016 5y median 0.6× FY 2025
P/FCF -1.8×
FY 2016 5y median -3.7× FY 2025
EV/EBITDA 1.2×
FY 2016 5y median 1.2× FY 2025
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -55.2%
FY 2016 5y median -15.7% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -32.4%
FY 2016 5y median -13.7% FY 2025
ROIC -39.2%
FY 2016 5y median -17.0% FY 2025
ROA -30.3%
FY 2016 5y median -13.4% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2025
Operating Income -31.1%
FY 2016 FY 2025
EPS (diluted) -18.3%
FY 2016 FY 2025
Free Cash Flow -24.6%
FY 2016 FY 2025
Financial Health
Current Ratio 16.0×
FY 2016 5y median 33.1× FY 2025
Quick Ratio 16.0×
FY 2016 5y median 33.1× FY 2025
Debt / Equity 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 2.9×
FY 2016 5y median 5.1× FY 2025
Interest Coverage -633×
FY 2016 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
